Authors
In this climate of debate it becomes paramount to identify a regulatory model which would best appease all parties with the least potential for a negative impact on public health.Such a model would have the primary goal of giving medicinal users access to a safe and evidence based product; however this system is in competition with already accessible unregulated cannabis use.The current changes in the US and other places offer the opportunity to observe several different models of regulation that are being implemented [20][21][22].
No takes yet. Share an insight, caveat, or question.
Gates et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: